Early diagnosis of Alzheimer's disease through handwriting analysis and deep learning: A review
Handwriting patterns analyzed by AI detect early Alzheimer's changes with over 80% accuracy, offering a simple noninvasive screening approach.
This PRISMA-informed review synthesizes handwriting-based and DL-based AD early detection studies, finding >80% accuracy in most models with multimodal approaches approaching 90% for structured tasks like clock drawing. Key limitations are small sample sizes, single-center designs, and lack of longitudinal validation, but the approach represents an accessible non-invasive cognitive biomarker platform.
What the study was
- Study design
- PRISMA-informed narrative systematic review
- Population
- AD/MCI patients vs healthy controls in handwriting/drawing digital biomarker studies
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Journal of Alzheimer's Disease
Why it surfaced
Useful landscape review for AI-based early AD detection via digital behavioral biomarkers. Accuracy limits in real-world settings and single-center evidence base keep this at standard/low tier. Field is developing but not yet validated for clinical use.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.